These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39044755)

  • 1. Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia.
    Tkachev AI; Stekolshchikova EA; Morozova AY; Anikanov NA; Zorkina YA; Alekseyeva PN; Khobta EB; Andreyuk DS; Zozulya SA; Barkhatova AN; Klyushnik TP; Reznik AM; Kostyuk GP; Khaitovich PE
    Consort Psychiatr; 2021; 2(3):35-43. PubMed ID: 39044755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI-HF trial.
    Targher G; Lunardi G; Mantovani A; Meessen J; Bonapace S; Temporelli PL; Nicolis E; Novelli D; Conti A; Tavazzi L; Maggioni AP; Latini R
    ESC Heart Fail; 2020 Dec; 7(6):3288-3297. PubMed ID: 32627354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.
    Laaksonen R; Ekroos K; Sysi-Aho M; Hilvo M; Vihervaara T; Kauhanen D; Suoniemi M; Hurme R; März W; Scharnagl H; Stojakovic T; Vlachopoulou E; Lokki ML; Nieminen MS; Klingenberg R; Matter CM; Hornemann T; Jüni P; Rodondi N; Räber L; Windecker S; Gencer B; Pedersen ER; Tell GS; Nygård O; Mach F; Sinisalo J; Lüscher TF
    Eur Heart J; 2016 Jul; 37(25):1967-76. PubMed ID: 27125947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes.
    Mantovani A; Altomari A; Lunardi G; Bonapace S; Lippi G; Bonnet F; Targher G
    Diabetes Metab; 2020 Sep; 46(4):326-330. PubMed ID: 31185304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography.
    Mantovani A; Bonapace S; Lunardi G; Canali G; Dugo C; Vinco G; Calabria S; Barbieri E; Laaksonen R; Bonnet F; Byrne CD; Targher G
    Diabetes Metab; 2020 Apr; 46(2):150-157. PubMed ID: 31386900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease.
    Mantovani A; Lunardi G; Bonapace S; Dugo C; Altomari A; Molon G; Conti A; Bovo C; Laaksonen R; Byrne CD; Bonnet F; Targher G
    Diabetes Metab; 2021 Feb; 47(1):101152. PubMed ID: 32283179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceramide ratios are affected by cigarette smoke but not heat-not-burn or e-vapor aerosols across four independent mouse studies.
    Lavrynenko O; Titz B; Dijon S; Santos DD; Nury C; Schneider T; Guedj E; Szostak J; Kondylis A; Phillips B; Ekroos K; Martin F; Peitsch MC; Hoeng J; Ivanov NV
    Life Sci; 2020 Dec; 263():118753. PubMed ID: 33189821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes.
    Mantovani A; Csermely A; Sani E; Beatrice G; Petracca G; Lunardi G; Bonapace S; Lippi G; Targher G
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy.
    Mantovani A; Bonapace S; Lunardi G; Salgarello M; Dugo C; Canali G; Byrne CD; Gori S; Barbieri E; Targher G
    Metabolism; 2018 Aug; 85():305-312. PubMed ID: 29777715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for quantifying hepatic and intestinal ceramides on mice by UPLC-MS/MS.
    Ge K; Zheng D; Wang J; Jia W; Zhao A
    Anal Biochem; 2023 Jan; 661():114982. PubMed ID: 36375519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating sphingolipids as biomarkers for the outcomes of acute ischemic stroke patients receiving endovascular treatment.
    Lee TH; Cheng CN; Lee CW; Kuo CH; Tang SC; Jeng JS
    J Formos Med Assoc; 2023 Jan; 122(1):19-28. PubMed ID: 36184387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Ceramide: A New Cardiometabolic Biomarker in Patients With Comorbid Acute Coronary Syndrome and Type 2 Diabetes Mellitus.
    Cao R; Fang Z; Li S; Xu M; Zhang J; Han D; Hu W; Yan L; Wang Y; Fan L; Cao F
    Front Physiol; 2020; 11():1104. PubMed ID: 33041846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceramides and phospholipids in plasma extracellular vesicles are associated with high risk of major cardiovascular events after carotid endarterectomy.
    Timmerman N; Waissi F; Dekker M; de Borst GJ; van Bennekom J; de Winter RJ; Hilvo M; Jylhä A; Pasterkamp G; de Kleijn DPV; Laaksonen R
    Sci Rep; 2022 Apr; 12(1):5521. PubMed ID: 35365690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between KLF6 rs3750861 polymorphism and plasma ceramide concentrations in post-menopausal women with type 2 diabetes.
    Mantovani A; Zusi C; Lunardi G; Bonapace S; Lippi G; Maffeis C; Targher G
    Nutr Metab Cardiovasc Dis; 2022 May; 32(5):1283-1287. PubMed ID: 35260314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes.
    Yu B; Hu M; Jiang W; Ma Y; Ye J; Wu Q; Guo W; Sun Y; Zhou M; Xu Y; Wu Z; Wang Y; Lam SM; Shui G; Gu J; Li JZ; Fu Z; Gong Y; Zhou H
    Lipids Health Dis; 2023 Oct; 22(1):166. PubMed ID: 37794463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide stearic to palmitic acid ratio predicts incident diabetes.
    Hilvo M; Salonurmi T; Havulinna AS; Kauhanen D; Pedersen ER; Tell GS; Meyer K; Teeriniemi AM; Laatikainen T; Jousilahti P; Savolainen MJ; Nygård O; Salomaa V; Laaksonen R
    Diabetologia; 2018 Jun; 61(6):1424-1434. PubMed ID: 29546476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma ceramides are associated with coronary atherosclerotic burden in patients with ST-segment elevation myocardial infarction.
    Pan W; Li L; Sun M; Wang C; Fang S; Yu B
    Int J Cardiol; 2020 Dec; 320():155-160. PubMed ID: 32800902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Ceramides and Cardiovascular Events in Hypertensive Patients at High Cardiovascular Risk.
    Yin W; Li F; Tan X; Wang H; Jiang W; Wang X; Li S; Zhang Y; Han Q; Wang Y; Du J
    Am J Hypertens; 2021 Nov; 34(11):1209-1216. PubMed ID: 34232291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of ceramide synthase 2 in hepatocytes modulates plasma ceramide biomarkers predictive of cardiovascular death.
    Schmidt S; Gallego SF; Zelnik ID; Kovalchuk S; Albæk N; Sprenger RR; Øverup C; Pewzner-Jung Y; Futerman AH; Lindholm MW; Jensen ON; Ejsing CS
    Mol Ther; 2022 Apr; 30(4):1661-1674. PubMed ID: 34400330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceramides and risk of major adverse cardiovascular events: A meta-analysis of longitudinal studies.
    Mantovani A; Dugo C
    J Clin Lipidol; 2020; 14(2):176-185. PubMed ID: 32067904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.